Preimplantation Genetic Testing Market Size, Share & Trends Analysis Report By Procedure (Preimplantation Genetic Screening (PGS), Preimplantation Genetic Diagnosis (PGD)), By Product (Reagents and Consumables, Instruments, Software), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridisation (FISH), Others), By Application (Chromosomal Abnormalities, Aneuploidy Screening, X-linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Others), By End-User (Hospitals, Fertility Centres, Diagnostic Centres, Research Centres and Academic Labs) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 03, 2026 | Author: Debashree B | Format:

Market Segmentation

  1. Preimplantation Genetic Testing Market, By Procedure 2022-2034 (USD MILLION/ Units)
    1. Preimplantation Genetic Screening (PGS)
    2. Preimplantation Genetic Diagnosis (PGD)
  2. Preimplantation Genetic Testing Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Reagents and Consumables
    2. Instruments
    3. Software
  3. Preimplantation Genetic Testing Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Next-Generation Sequencing (NGS)
    2. Polymerase Chain Reaction (PCR)
    3. Fluorescent In Situ Hybridisation (FISH)
    4. Others
  4. Preimplantation Genetic Testing Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Chromosomal Abnormalities
    2. Aneuploidy Screening
    3. X-linked Diseases
    4. Embryo Testing
    5. Human Leukocyte Antigen (HLA) Typing
    6. Others
  5. Preimplantation Genetic Testing Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Fertility Centres
    3. Diagnostic Centres
    4. Research Centres and Academic Labs
  6. Regional Preimplantation Genetic Testing Market
    1. North America
      1. North America Preimplantation Genetic Testing Market By Procedure 2022-2034 (USD MILLION/ Units)
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
      2. North America Preimplantation Genetic Testing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagents and Consumables
        2. Instruments
        3. Software
      3. North America Preimplantation Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Fluorescent In Situ Hybridisation (FISH)
        4. Others
      4. North America Preimplantation Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chromosomal Abnormalities
        2. Aneuploidy Screening
        3. X-linked Diseases
        4. Embryo Testing
        5. Human Leukocyte Antigen (HLA) Typing
        6. Others
      5. North America Preimplantation Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Fertility Centres
        3. Diagnostic Centres
        4. Research Centres and Academic Labs
      6. U.S.
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      7. Canada
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
    2. Europe
      1. Europe Preimplantation Genetic Testing Market By Procedure 2022-2034 (USD MILLION/ Units)
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
      2. Europe Preimplantation Genetic Testing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagents and Consumables
        2. Instruments
        3. Software
      3. Europe Preimplantation Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Fluorescent In Situ Hybridisation (FISH)
        4. Others
      4. Europe Preimplantation Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chromosomal Abnormalities
        2. Aneuploidy Screening
        3. X-linked Diseases
        4. Embryo Testing
        5. Human Leukocyte Antigen (HLA) Typing
        6. Others
      5. Europe Preimplantation Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Fertility Centres
        3. Diagnostic Centres
        4. Research Centres and Academic Labs
      6. U.K.
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      7. Germany
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      8. France
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      9. Spain
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      10. Italy
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      11. Russia
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      12. Nordic
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      13. Benelux
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      14. Rest of Europe
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
    3. APAC
      1. APAC Preimplantation Genetic Testing Market By Procedure 2022-2034 (USD MILLION/ Units)
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
      2. APAC Preimplantation Genetic Testing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagents and Consumables
        2. Instruments
        3. Software
      3. APAC Preimplantation Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Fluorescent In Situ Hybridisation (FISH)
        4. Others
      4. APAC Preimplantation Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chromosomal Abnormalities
        2. Aneuploidy Screening
        3. X-linked Diseases
        4. Embryo Testing
        5. Human Leukocyte Antigen (HLA) Typing
        6. Others
      5. APAC Preimplantation Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Fertility Centres
        3. Diagnostic Centres
        4. Research Centres and Academic Labs
      6. China
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      7. Korea
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      8. Japan
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      9. India
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      10. Australia
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      11. Taiwan
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      12. South East Asia
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      13. Rest of Asia-Pacific
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
    4. Middle East and Africa
      1. Middle East and Africa Preimplantation Genetic Testing Market By Procedure 2022-2034 (USD MILLION/ Units)
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
      2. Middle East and Africa Preimplantation Genetic Testing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagents and Consumables
        2. Instruments
        3. Software
      3. Middle East and Africa Preimplantation Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Fluorescent In Situ Hybridisation (FISH)
        4. Others
      4. Middle East and Africa Preimplantation Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chromosomal Abnormalities
        2. Aneuploidy Screening
        3. X-linked Diseases
        4. Embryo Testing
        5. Human Leukocyte Antigen (HLA) Typing
        6. Others
      5. Middle East and Africa Preimplantation Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Fertility Centres
        3. Diagnostic Centres
        4. Research Centres and Academic Labs
      6. UAE
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      7. Turkey
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      8. Saudi Arabia
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      9. South Africa
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      10. Egypt
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      11. Nigeria
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      12. Rest of MEA
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
    5. LATAM
      1. LATAM Preimplantation Genetic Testing Market By Procedure 2022-2034 (USD MILLION/ Units)
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
      2. LATAM Preimplantation Genetic Testing Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagents and Consumables
        2. Instruments
        3. Software
      3. LATAM Preimplantation Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Fluorescent In Situ Hybridisation (FISH)
        4. Others
      4. LATAM Preimplantation Genetic Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chromosomal Abnormalities
        2. Aneuploidy Screening
        3. X-linked Diseases
        4. Embryo Testing
        5. Human Leukocyte Antigen (HLA) Typing
        6. Others
      5. LATAM Preimplantation Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Fertility Centres
        3. Diagnostic Centres
        4. Research Centres and Academic Labs
      6. Brazil
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      7. Mexico
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      8. Argentina
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      9. Chile
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      10. Colombia
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs
      11. Rest of LATAM
        1. Preimplantation Genetic Screening (PGS)
        2. Preimplantation Genetic Diagnosis (PGD)
        3. Reagents and Consumables
        4. Instruments
        5. Software
        6. Next-Generation Sequencing (NGS)
        7. Polymerase Chain Reaction (PCR)
        8. Fluorescent In Situ Hybridisation (FISH)
        9. Others
        10. Chromosomal Abnormalities
        11. Aneuploidy Screening
        12. X-linked Diseases
        13. Embryo Testing
        14. Human Leukocyte Antigen (HLA) Typing
        15. Others
        16. Hospitals
        17. Fertility Centres
        18. Diagnostic Centres
        19. Research Centres and Academic Labs

We are featured on: